Sign In
Buy RMTI
$7.19
+0.0900 (+1.27%)
At Close: Jul 31, 2026
Rockwell Medical Partners with HydroCare to Distribute and Install its Dry Acid Concentrate Mix System
06:00am, Thursday, 05'th Dec 2024
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical's DAMX45 dry acid concentrate mix system is 510(k) approved to be used exclusively with the Company's dry acid concentr
Rockwell Medical Expands Distribution in the Philippines
06:00am, Tuesday, 19'th Nov 2024
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will be the exclusive supplier of all dry hemodialysis concentrates products to Nephro Group.
Rockwell Medical's Dip Gives A Speculative Opportunity
07:25am, Wednesday, 13'th Nov 2024
Despite a 39% stock drop yesterday, Rockwell Medical's strong Q3 results and upcoming catalyst provide a solid buying opportunity for risk-takers. The stock's dip was due to reduced orders from its la
Rockwell Medical, Inc. (RMTI) Q3 2024 Earnings Call Transcript
11:30am, Tuesday, 12'th Nov 2024
Rockwell Medical, Inc. (NASDAQ:RMTI ) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Heather Hunter - Senior Vice President & Chief Corporate Affairs Officer Mark S
Rockwell Medical (RMTI) Surpasses Q3 Earnings and Revenue Estimates
08:10am, Tuesday, 12'th Nov 2024
Rockwell Medical (RMTI) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to loss of $0.07 per share a year ago.
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical today announced financial and operational results for the three and nine months ended September 30, 2024.
Rockwell Medical Announces Date Change for Third Quarter 2024 Earnings Conference Call and Webcast
06:00am, Friday, 08'th Nov 2024
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--UPDATED Q3'24 EARNINGS DATE: Rockwell Medical will release its third quarter 2024 financial and operational results on November 12, 2024
RMTI Stock Rises 138% in Q3: What Should You Do Ahead of Earnings?
11:56am, Thursday, 31'st Oct 2024
Rockwell Medical expects its Q3 results to gain from a high rate of customer conversions toward it compared with its primary competitor.
Rockwell Medical on Expansion Spree: Should You Buy the Stock Now?
11:36am, Friday, 18'th Oct 2024
This year can be regarded as a momentous period for RMTI's business because this is the first time in its history that it has achieved steady revenue growth.
Rockwell Medical (RMTI) Upgraded to Buy: Here's Why
01:01pm, Thursday, 17'th Oct 2024
Rockwell Medical (RMTI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Rockwell Medical to Release Third Quarter 2024 Results on Monday, November 11, 2024
06:00am, Monday, 14'th Oct 2024
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its financial and operational results for the third quarter ended September 30, 2024 on Monday, November 1
Rockwell Medical, Inc. (RMTI) Hits Fresh High: Is There Still Room to Run?
10:16am, Friday, 20'th Sep 2024
Rockwell Medical (RMTI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Rockwell Medical Stock Surges 108.5% YTD: Should You Snap it Up Now?
01:31pm, Wednesday, 18'th Sep 2024
RMTI continues to outperform its peers, banking on its focus on optimizing business to drive sustainable profitability and meaningful cash flow generation.
Rockwell Medical Named a Fortune 'Best Workplaces in Manufacturing & Production'
06:00am, Wednesday, 18'th Sep 2024
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Great Place to Work and Fortune magazine selected Rockwell Medical for the 2024 Fortune Best Workplaces in Manufacturing and Production
Rockwell Medical: The Turnaround Is Looking Real
02:06pm, Sunday, 15'th Sep 2024
Rockwell develop concentrates for hemodialysis, which is a process that seeks to artificially replace kidney function in patients with chronic failure. Despite being a critical product, there's curren
